ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,800Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 2094

$1.36M Total Retail Price of All Prescriptions

Rank: 33 out of 2094

873 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 873 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 873 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 19,186 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 937 862 1 3
OMEPRAZOLE 753 731 2 4
WARFARIN SODIUM 656 598 3 11
FUROSEMIDE 619 608 4 6
METOPROLOL TARTRATE 547 520 5 10
SIMVASTATIN 516 479 6 1
DONEPEZIL HCL 501 500 7 20
LISINOPRIL 460 419 8 7
AMLODIPINE BESYLATE 406 367 9 2
METOPROLOL SUCCINATE 332 332 10 9
POTASSIUM CHLORIDE 331 310 11 24
HYDROCODONE-ACETAMINOPHEN 302 265 S3 12 42
METFORMIN HCL 288 256 13 8
HYDROCHLOROTHIAZIDE 268 262 14 12
CITALOPRAM HBR 253 251 15 47
PREDNISONE 251 242 16 54
TORSEMIDE 233 199 17 118
ENALAPRIL MALEATE 228 221 18 25
NAMENDA 226 226 19 32
FENTANYL 217 213 S2 20 68
DIGOXIN 215 203 21 51
OXYCODONE-ACETAMINOPHEN 212 209 S2 22 40
GABAPENTIN 200 176 23 23
QUETIAPINE FUMARATE 197 195 24 71
GLIMEPIRIDE 188 187 25 31
CARVEDILOL 180 178 26 19
JANUVIA 178 168 27 35
CLOPIDOGREL 176 157 28 22
DIOVAN 174 167 29 13
FAMOTIDINE 171 167 30 34
CYMBALTA 167 121 31 61
ZOLPIDEM TARTRATE 167 154 31 14
MIRTAZAPINE 161 161 33 43
NYSTATIN-TRIAMCINOLONE 160 160 34 207
RAMIPRIL 156 138 35 48
SPIRONOLACTONE 149 145 36 93
ATENOLOL 147 142 37 21
SERTRALINE HCL 141 139 38 26
ATORVASTATIN CALCIUM 132 126 39 5
PAROXETINE HCL 126 103 40 77
NIFEDIPINE ER 124 119 41 96
LOSARTAN POTASSIUM 123 119 42 17
ESCITALOPRAM OXALATE 122 122 43 46
CLOTRIMAZOLE-BETAMETHASONE 120 120 44 91
ALBUTEROL SULFATE 120 114 44 90
CARBIDOPA-LEVODOPA 115 115 46 102
PRAVASTATIN SODIUM 114 101 47 18
AZITHROMYCIN 111 98 48 27
TAMSULOSIN HCL 111 111 48 29
LIDODERM 107 107 50 59
PLAVIX 107 95 50 38
ADVAIR DISKUS 106 99 52 36
TRAMADOL HCL 104 91 53 33
CRESTOR 103 91 54 15
LACTULOSE 100 94 55 65
OXYBUTYNIN CHLORIDE ER 99 88 56 138
ALENDRONATE SODIUM 99 98 56 30
NITROGLYCERIN PATCH 98 97 58 101
IPRATROPIUM-ALBUTEROL 95 74 59 92
LEVETIRACETAM 95 54 59 78
NOVOLOG 93 79 61 116
ALLOPURINOL 93 75 61 50
OXYCODONE HCL 93 30 S2 61 63
LEVOFLOXACIN 87 82 64 70
EXELON 85 85 65 111
LANTUS 80 56 66 66
OXYCONTIN 79 66 S2 67 98
VESICARE 77 73 68 152
NITROFURANTOIN MONO-MACRO 77 76 68 265
ISOSORBIDE MONONITRATE ER 76 62 70 57
PANTOPRAZOLE SODIUM 74 74 71 37
CIPROFLOXACIN HCL 72 70 72 81
OXYCODONE HCL-ACETAMINOPHEN 70 18 S2 73 119
SEROQUEL 70 70 73 172
LATANOPROST 69 69 75 153
RISPERIDONE 67 67 76 56
LYRICA 65 65 77 85
DILTIAZEM 24HR CD 62 62 78 110
LUMIGAN 62 62 78 321
ABILIFY 62 62 78 165
BUDESONIDE 60 49 81 228
SANTYL 59 37 82 114
NYSTATIN 59 59 82 167
VENLAFAXINE HCL ER 58 58 84 183
LAMOTRIGINE 54 23 85 177
ALPRAZOLAM 54 46 85 150
SYNTHROID 54 44 85 44
PROPRANOLOL HCL 53 39 88 245
CEPHALEXIN 52 49 89 201
TRAZODONE HCL 51 48 90 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.